These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26737337)

  • 41. Overground vs. treadmill-based robotic gait training to improve seated balance in people with motor-complete spinal cord injury: a case report.
    Chisholm AE; Alamro RA; Williams AM; Lam T
    J Neuroeng Rehabil; 2017 Apr; 14(1):27. PubMed ID: 28399877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tizanidine treatment of spasticity caused by multiple sclerosis: results of a double-blind, placebo-controlled trial. US Tizanidine Study Group.
    Smith C; Birnbaum G; Carter JL; Greenstein J; Lublin FD
    Neurology; 1994 Nov; 44(11 Suppl 9):S34-42; discussion S42-3. PubMed ID: 7970009
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacological interventions for spasticity following spinal cord injury: results of a Cochrane systematic review.
    Taricco M; Pagliacci MC; Telaro E; Adone R
    Eura Medicophys; 2006 Mar; 42(1):5-15. PubMed ID: 16565680
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Medical treatment of spasticity].
    Rode G; Maupas E; Luaute J; Courtois-Jacquin S; Boisson D
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):247-55. PubMed ID: 12746699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Open-label dose-titration safety and efficacy study of tizanidine hydrochloride in the treatment of spasticity associated with chronic stroke.
    Gelber DA; Good DC; Dromerick A; Sergay S; Richardson M
    Stroke; 2001 Aug; 32(8):1841-6. PubMed ID: 11486114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury.
    Kamen L; Henney HR; Runyan JD
    Curr Med Res Opin; 2008 Feb; 24(2):425-39. PubMed ID: 18167175
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multi-centre, double-blind trial of a novel antispastic agent, tizanidine, in spasticity associated with multiple sclerosis.
    Eyssette M; Rohmer F; Serratrice G; Warter JM; Boisson D
    Curr Med Res Opin; 1988; 10(10):699-708. PubMed ID: 3286128
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tizanidine and electrophysiologic analysis of spinal control mechanisms in humans with spasticity.
    Delwaide PJ; Pennisi G
    Neurology; 1994 Nov; 44(11 Suppl 9):S21-7; discussion S27-8. PubMed ID: 7970007
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lokomat robotic-assisted versus overground training within 3 to 6 months of incomplete spinal cord lesion: randomized controlled trial.
    Alcobendas-Maestro M; Esclarín-Ruz A; Casado-López RM; Muñoz-González A; Pérez-Mateos G; González-Valdizán E; Martín JL
    Neurorehabil Neural Repair; 2012; 26(9):1058-63. PubMed ID: 22699827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of a simple spasticity quantification method: effects of tizanidine on spasticity in patients with sequelae of cerebrovascular disease.
    Ogawa N; Asanuma M; Hirata H; Ota Z; Yamawaki Y; Yamamoto M
    J Int Med Res; 1992 Feb; 20(1):78-86. PubMed ID: 1568522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of Extracorporeal Shock Wave Therapy on Lower Limb Spasticity in Stroke Patients.
    Taheri P; Vahdatpour B; Mellat M; Ashtari F; Akbari M
    Arch Iran Med; 2017 Jun; 20(6):338-343. PubMed ID: 28646841
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment of spasticity].
    Autti-Rämö I
    Duodecim; 1999; 115(8):877-85. PubMed ID: 11859520
    [No Abstract]   [Full Text] [Related]  

  • 53. A double-blind, long-term study of tizanidine ('Sirdalud') in spasticity due to cerebrovascular lesions.
    Medici M; Pebet M; Ciblis D
    Curr Med Res Opin; 1989; 11(6):398-407. PubMed ID: 2651016
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuromuscular properties of different spastic human joints vary systematically.
    Mirbagheri MM; Settle K
    Annu Int Conf IEEE Eng Med Biol Soc; 2010; 2010():4894-7. PubMed ID: 21096656
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic effects of robotic rehabilitation on Neural and Muscular Abnormalities associated with the Spastic Ankle in Stroke Survivors.
    Lotfian M; Noroozi S; Dadashi F; Kharazi MR; Mirbagheri MM
    Annu Int Conf IEEE Eng Med Biol Soc; 2020 Jul; 2020():3860-3863. PubMed ID: 33018843
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Tizanidine as treatment of spasticity in patients with hemiplegia caused by a CVA or brain injury].
    Weynants L; Van Laere M
    Acta Belg Med Phys; 1990; 13(1):19-22. PubMed ID: 2336897
    [No Abstract]   [Full Text] [Related]  

  • 57. Tizanidine for spasticity.
    Med Lett Drugs Ther; 1997 Jul; 39(1004):62-3. PubMed ID: 9217694
    [No Abstract]   [Full Text] [Related]  

  • 58. Oral baclofen increases maximal voluntary neuromuscular activation of ankle plantar flexors in children with spasticity due to cerebral palsy.
    van Doornik J; Kukke S; McGill K; Rose J; Sherman-Levine S; Sanger TD
    J Child Neurol; 2008 Jun; 23(6):635-9. PubMed ID: 18281622
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The combined effects of clonidine and cyproheptadine with interactive training on the modulation of locomotion in spinal cord injured subjects.
    Fung J; Stewart JE; Barbeau H
    J Neurol Sci; 1990 Dec; 100(1-2):85-93. PubMed ID: 2089144
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Robot controlled, continuous passive movement of the ankle reduces spinal cord excitability in participants with spasticity: a pilot study.
    Noble S; Pearcey GEP; Quartly C; Zehr EP
    Exp Brain Res; 2019 Dec; 237(12):3207-3220. PubMed ID: 31599345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.